Literature DB >> 1432505

Ocular findings of incontinentia pigmenti in a male infant with Klinefelter syndrome.

S M Fowell1, M J Greenwald, J S Prendiville, L M Jampol.   

Abstract

A male infant with Klinefelter karyotype (47, XXY) manifested both the typical dermatologic findings of the X-linked dominant disorder incontinentia pigmenti (Bloch-Sulzberger syndrome) and ocular findings including retinal pigmentary changes, peripheral retinal avascularity, and preretinal fibrovascular proliferation. To our knowledge, this is the first reported case of incontinentia pigmenti with this specific abnormal genotype manifesting ocular findings.

Entities:  

Mesh:

Year:  1992        PMID: 1432505     DOI: 10.3928/0191-3913-19920501-13

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  3 in total

1.  Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome.

Authors:  S Kenwrick; H Woffendin; T Jakins; S G Shuttleworth; E Mayer; L Greenhalgh; J Whittaker; S Rugolotto; T Bardaro; T Esposito; M D'Urso; F Soli; A Turco; A Smahi; D Hamel-Teillac; S Lyonnet; J P Bonnefont; A Munnich; S Aradhya; C D Kashork; L G Shaffer; D L Nelson; M Levy; R A Lewis
Journal:  Am J Hum Genet       Date:  2001-10-22       Impact factor: 11.025

Review 2.  Systemic and ocular manifestations of a patient with mosaic ARID1A-associated Coffin-Siris syndrome and review of select mosaic conditions with ophthalmic manifestations.

Authors:  Virginia Miraldi Utz; Diana S Brightman; Monica A Sandoval; Robert B Hufnagel; Howard M Saal
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-09-05       Impact factor: 3.359

3.  Vitrectomy for Proliferative Diabetic Retinopathy Associated with Klinefelter Syndrome.

Authors:  Kensuke Tajiri; Kohei Otsuki; Takaki Sato; Daisaku Kimura; Takatoshi Kobayashi; Teruyo Kida; Jun Sugasawa; Tsunehiko Ikeda
Journal:  Case Rep Ophthalmol       Date:  2015-12-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.